biliari
atresia
ba
devast
fibroinflammatori
diseas
character
obstruct
extrahepat
intrahepat
bile
duct
infant
fatal
consequ
treat
time
manner
common
indic
pediatr
liver
transplant
worldwid
develop
new
therapi
allevi
need
surgic
intervent
hinder
due
complex
lack
understand
diseas
pathogenesi
reason
signific
effort
made
toward
develop
experiment
model
strategi
understand
etiolog
diseas
mechan
identifi
novel
therapeut
target
character
model
ba
use
rhesu
rotaviru
type
infect
newborn
balbc
mice
enabl
identif
key
cellular
molecular
target
involv
epitheli
injuri
duct
obstruct
howev
establish
unleash
chronic
inflamm
follow
progress
patholog
wound
heal
process
remain
poorli
understood
like
cell
macrophag
adopt
differ
function
program
proinflammatori
resolut
macrophag
influenc
surround
cytokin
environ
cell
respons
injuri
review
provid
overview
immunopathogenesi
ba
discuss
implic
innat
immun
diseas
pathogenesi
highlight
suitabl
therapeut
target
biliari
atresia
ba
devast
oblit
cholangiopathi
affect
exclus
infant
character
progress
fibroinflammatori
obstruct
extrahepat
intrahepat
bile
duct
lead
cirrhosi
liver
failur
ba
occur
birth
us
affect
ethnic
group
higher
frequenc
girl
despit
low
incid
ba
common
caus
neonat
cholestasi
endstag
liver
diseas
children
number
one
indic
pediatr
liver
transplant
worldwid
first
diseas
symptom
includ
jaundic
alcohol
stool
dark
urin
high
level
serum
bilirubin
conclus
diagnosi
ba
base
exploratori
surgeri
obstruct
extrahepat
biliari
tree
observ
confirm
histolog
analysi
liver
biliari
tissu
biopsi
time
diagnosi
day
life
averag
obstruct
extrahepat
remnant
remov
hepatoportoenterostomi
hpe
call
kasai
perform
restor
bile
flow
howev
even
kasai
procedur
perform
first
month
life
cholestasi
resolv
bile
duct
prolifer
fibrosi
persist
result
develop
variabl
degre
liver
fibrosi
cirrhosi
portal
hypertens
sever
hepat
complic
notabl
longterm
surviv
ba
patient
extraordinarili
improv
last
decadesfrom
treatment
still
reli
surgeri
hpe
transplant
palli
therebi
highlight
necess
develop
novel
target
therapi
prevent
revers
liver
injuri
tradit
ba
patient
divid
embryonicdevelopment
ba
perinatalacquir
ba
depend
onset
former
believ
origin
first
trimest
pregnanc
accompani
clinic
featur
suggest
development
origin
latter
thought
appear
shortli
birth
first
symptom
becom
recogniz
presenc
splenic
malformationspolysplenia
also
aspleniai
characterist
biliari
atresia
splenic
malform
basm
syndrom
repres
form
embryon
ba
infant
within
group
found
wors
prognosi
infant
isol
ba
remain
subgroup
compris
patient
least
one
nonsplen
malform
group
also
often
includ
categori
nonsyndrom
ba
sinc
presenc
underli
defect
necessarili
worsen
diseas
implic
differ
mechan
pathogenesi
notabl
basm
patient
may
also
anoth
concomit
defect
cardiovascular
later
defect
davenport
propos
latest
refer
classif
incorpor
cytomegaloviru
cmv
associ
cystic
ba
variant
aforement
nonsyndrom
ba
basm
group
cmvassoci
ba
refer
subgroup
infant
whose
liver
biopsi
stain
posit
immunoglobulin
igm
antibodi
cmv
presenc
antibodi
link
poorest
hpe
outcom
highest
mortal
tissu
biopsi
reveal
exacerb
proinflammatori
respons
predomin
cellular
profil
observ
ba
patient
contrast
cystic
ba
anatom
variant
cyst
form
close
site
obstruct
prime
associ
improv
drainag
hpe
better
longterm
outcom
etiolog
ba
heterogen
fulli
elucid
yet
divers
theori
regard
caus
diseas
formul
includ
embryon
development
abnorm
exposur
exogen
trigger
virus
toxin
immun
immatur
immun
dysregul
autoimmun
furthermor
numer
suscept
factorssuch
genet
predisposit
matern
diabet
microchimer
also
implic
pathogenesi
diseas
complex
cocktail
variabl
factor
support
claim
biliari
atresia
diseas
singl
etiolog
combin
differ
phenotyp
share
certain
clinic
featur
obliter
biliari
tree
earli
life
characterist
lesion
ba
obstruct
extrahepat
biliari
tree
cholestasi
success
reproduc
investig
sever
anim
modelssuch
lamb
calf
zebrafish
mous
first
three
form
experiment
ba
lamb
calf
zebrafish
induc
toxin
murin
model
achiev
upon
viral
infect
one
first
observ
balik
patholog
anim
report
australian
outbreak
lamb
born
cholestasi
pregnant
livestock
expos
unidentifi
toxic
environment
factor
extrem
drought
condit
aros
suspicion
toxic
effect
could
come
grass
group
scientist
univers
pennsylvania
import
plant
speci
characterist
area
use
zebrafish
bioassay
identifi
substanc
respons
isoflavonoid
name
biliatreson
toxic
compound
capabl
induc
biliari
atresia
phenotyp
basi
theori
implic
hepatotoxin
etiolog
agent
lead
theori
origin
diseas
point
toward
viral
insult
first
implic
hepatotrop
viru
caus
factor
ba
suggest
benjamin
land
despit
initi
contradictori
find
regard
presenc
role
reoviru
ba
numer
virus
implic
patholog
diseas
evid
preced
viral
infectionmxa
protein
myxoviru
resist
protein
could
found
even
absenc
viral
materi
whether
viru
primari
caus
factor
accident
secondari
event
remain
unclear
among
virus
rhesu
rotaviru
type
rrv
gold
standard
model
ba
mice
use
murin
model
facilit
studi
differ
aspect
diseas
underli
mechan
pathogenesi
identif
novel
therapeut
target
experiment
form
ba
use
balbc
newborn
mice
challeng
rrv
within
first
hour
life
h
recapitul
mani
aspect
human
ba
timerestrict
suscept
viral
infect
portal
tract
infiltr
inflammatori
cell
obstruct
extrahepat
intrahepat
biliari
tree
vivo
model
allow
comprehens
studi
earli
event
diseas
explor
directli
human
sinc
happen
time
diagnosi
howev
rrv
model
yet
suitabl
studi
progress
diseas
duct
obstruct
due
high
mortal
rate
mice
develop
liver
fibrosi
relat
longterm
complic
previou
studi
examin
fibrogen
respons
rrv
model
observ
insuffici
fibrosi
ishak
score
determin
week
time
figur
limit
eg
high
mortal
poor
fibrogen
respons
howev
could
tackl
optim
model
induct
use
reassort
virus
recent
novel
rrvtuch
rotaviru
reassort
tuch
tulan
univers
cincinnati
children
hospit
could
recapitul
obstruct
jaundic
phenotyp
lower
mortal
rate
inject
newborn
mice
new
model
recapitul
late
event
diseas
liver
fibrosi
ishak
score
show
uniqu
resembl
human
ba
significantli
differ
ccl
bile
duct
ligat
model
figur
model
therefor
improv
current
understand
ba
diseas
pathogenesi
also
contribut
toward
identif
new
therapeut
target
cytomegaloviru
cmv
also
use
recapitul
ba
anim
model
instanc
regulatori
cell
treg
deplet
neonat
mous
infect
lowdos
cmv
ldcmv
studi
ba
induc
extens
inflamm
atresia
intrahepat
bile
duct
partial
obstruct
extrahepat
bile
duct
liver
mononuclear
cell
show
increas
percentag
cell
serum
autoantibodi
reactiv
bile
duct
epitheli
protein
suggest
involv
cellular
humor
autoimmun
respons
ldcmv
ba
mous
model
also
increas
hepat
express
gene
tumor
necrosi
factor
interferon
activ
gene
signal
transduc
activ
transcript
cytokineschemokin
lymphotactin
interleukin
macrophag
inflammatori
protein
mention
earlier
virus
propos
etiolog
agent
ba
virus
activ
pathway
might
predispos
certain
individu
develop
diseas
anim
model
rrv
viral
protein
gene
demonstr
major
determin
factor
requir
pathogenesi
ba
rotaviru
strain
homolog
rrv
capabl
infect
murin
bile
duct
induc
diseas
well
activ
mononuclear
cell
independ
viral
titer
research
led
identif
key
amino
acid
sequenc
srl
sequenc
specif
rotaviru
strain
caus
obstruct
cholangiopathi
tripeptid
srl
rrv
found
bind
specif
cholangiocyt
membran
protein
heat
shock
cognat
defin
novel
bind
site
govern
attach
gain
insight
mechan
involv
upon
infect
revers
genet
system
develop
creat
mutant
rrv
singl
amino
acid
chang
protein
compar
wildtyp
rrv
arginin
r
srl
region
replac
glycin
g
mutant
viru
inject
mice
demonstr
reduc
symptom
lower
mortal
neonat
mice
result
attenu
form
biliari
atresia
indic
import
srl
region
srl
peptid
also
found
either
capsid
attach
protein
virus
includ
reoviru
cytomegaloviru
human
papillomaviru
epsteinbarr
viru
bluetongu
viru
polyomaviru
coronaviru
respiratori
syncyti
viru
adenoviru
rodent
paramyxoviru
herp
simplex
viru
sever
cytomegaloviru
epsteinbarr
viru
human
papillomaviru
reoviru
detect
explant
liver
infant
ba
thu
sequenc
abovement
virus
might
involv
cholangiocyt
bind
similar
fashion
rrv
srl
peptid
bind
virus
might
activ
innat
immun
system
differ
pathway
role
bind
human
ba
induct
function
protein
influenc
oxid
stress
cell
metabol
remain
larg
unexplor
biliari
epitheli
cell
cholangiocyt
physic
barrier
drain
bile
duodenum
also
immunocompet
cell
involv
tissu
homeostasi
capabl
recogn
microbi
conserv
motif
known
pathogen
associ
molecular
pattern
pamp
patternrecognit
receptor
prr
initi
inflammatori
respons
four
main
famili
prr
describ
includ
tolllik
receptor
tlr
retino
acid
induc
gene
rigi
like
receptor
rlr
nucleotidebind
oligomer
domain
nod
like
receptor
nlr
ctype
lectin
receptor
clr
ten
type
tlr
identifi
mammal
least
describ
mice
human
cholangiocyt
among
respons
sens
lipopolysaccharid
lp
involv
recognit
viral
bacteri
rna
dna
activ
receptor
trigger
inflammatori
respons
via
mitogenactiv
protein
kinas
mapk
interferon
regulatori
factor
andor
nuclear
factor
character
product
type
interferon
ifn
andor
proinflammatori
cytokin
mapk
signal
multifunct
pathway
pivot
innat
immun
respons
viral
infect
among
three
central
member
mapk
pathway
extracellular
signalregul
kinas
erk
activ
play
import
role
rrv
infect
cholangiocyt
seem
involv
viral
replic
epitheli
injuri
studi
reveal
erk
phosphoryl
calcium
influx
appear
essenti
rrv
infect
rrv
viral
protein
drive
erk
phosphoryl
tlr
depend
adaptor
moleculesmyeloid
differenti
primari
respons
receptor
domaincontain
adaptor
protein
trif
effect
initi
transduc
downstream
signal
nuclei
differenti
two
main
tlr
signal
pathway
figur
pathway
associ
tlr
except
receptorassoci
kinas
irak
upregul
product
type
ifn
proinflammatori
cytokin
via
mapk
pathway
demonstr
pathogenesi
murin
ba
independ
signal
pathway
independ
pathway
activ
associ
trifdepend
signal
result
activ
signal
cascad
differ
level
regul
could
explain
endotoxin
toler
enter
bacteria
induc
cultur
cholangiocyt
treat
ligand
like
lp
viral
toler
could
achiev
use
approach
rlr
famili
compris
cytosol
sensor
includ
melanoma
differentiationassoci
protein
capabl
bind
dsrna
interact
trigger
conform
chang
expos
two
caspas
activ
recruit
domain
card
nterminu
respons
recruit
complementari
protein
mitochondri
antiviralsign
protein
mav
transduc
signal
nuclei
produc
type
interferon
proinflammatori
cytokin
figur
nlr
eg
also
cytosol
innat
immun
receptor
activ
upon
recognit
viral
dsrna
rather
contribut
initi
event
acut
inflammatori
respons
amplifi
immun
respons
releas
late
mediat
high
mobil
group
box
regul
pyroptosi
proinflammatori
program
cell
death
format
inflammasom
figur
last
group
prr
describ
larg
famili
clr
transmembran
receptor
immunoreceptor
tyrosinebas
activ
motif
itam
immunoreceptor
tyrosinebas
inhibit
motif
itim
abl
induc
proinflammatori
respons
modul
crosstalk
prr
tlr
clr
play
crucial
role
maintain
immun
homeostasi
pathogen
mount
proinflammatori
andor
antivir
respons
alter
clr
implic
differ
patholog
condit
includ
gastrointestin
cancer
autoimmun
disord
allergi
known
cell
myeloid
lineag
dendrit
cell
dc
macrophag
well
endotheli
epitheli
cell
express
clr
howev
report
biliari
epithelium
yet
although
cholangiocyt
play
central
role
initi
immun
respons
upon
exposur
exogen
substanc
howev
capabl
mount
inflamm
suffici
induc
chemotaxi
recapitul
obstruct
phenotyp
ba
without
involv
macrophag
dc
upon
viral
infect
cholangiocyt
macrophag
dc
rrv
cellular
target
trigger
antivir
respons
type
interferon
autocrin
paracrin
manner
infect
surround
cell
prevent
viru
spread
infect
cell
type
ifn
promot
biliari
apoptosi
upregul
tumor
necrosi
factor
relat
frontier
immunolog
wwwfrontiersinorg
februari
volum
articl
apoptosi
ligand
trail
tnf
receptor
ligand
surround
tissu
ifn
trigger
product
antivir
protein
mx
provid
protect
viral
infect
figur
product
proinflammatori
cytokin
chemokin
cholangiocyt
macrophag
dc
creat
favor
microenviron
recruit
activ
inflammatori
cell
promot
immun
effector
tissuespecif
attack
figur
among
chemokin
produc
relev
mostli
produc
macrophag
also
cholangiocyt
recruit
modul
action
neutrophil
basophil
monocyt
cell
secret
primarili
dc
attract
regul
activ
natur
killer
nk
natur
killer
nkt
gammadelta
cell
recruit
inflammatori
effector
cell
engag
target
specif
biliari
epithelium
contact
depend
manner
cytokin
andor
cytotox
agent
perforin
granzym
recruit
neutrophil
produc
reactiv
oxygen
speci
ro
leukotrien
neutrophil
defensin
nk
cell
activ
dc
via
induc
cholangiocyt
death
contactdepend
manner
natur
killer
group
ligand
interact
ribonucl
acid
export
receptor
express
infect
cell
via
secret
perforin
granzym
similar
fashion
cytotox
power
neonat
cell
exert
cytotox
agent
perforin
granzym
contactdepend
manner
invad
epithelium
mechanist
studi
use
rrvinfect
balbc
murin
model
show
deplet
nk
cell
blockag
receptor
deplet
cell
impair
mechan
reduc
cholangiocyt
death
evad
ruptur
epithelium
ultim
prevent
obstruct
extrahepat
biliari
tree
likewis
epitheli
integr
preserv
deplet
plasmacytoid
dc
block
signal
respons
nk
cell
activ
result
highlight
specif
role
dc
nk
cell
model
inflamm
progress
without
resolv
dc
macrophag
interact
chiefli
helper
cell
promot
activ
oligoclon
expans
differenti
special
phenotyp
depend
predomin
cytokin
microenviron
time
figur
ba
patient
microenviron
proinflammatori
character
product
activ
effector
cell
macrophag
cell
b
cell
perpetu
tissu
damag
figur
case
infant
capabl
mount
respons
therefor
polar
prime
produc
type
innat
lymphoid
cell
predomin
cytokin
respons
tissu
damag
mediat
ductal
prolifer
activ
hepat
stellat
cell
hsc
portal
fibroblast
typic
case
aforement
cystic
variant
ba
depict
figur
contrast
tcell
polar
littl
known
implic
humor
immun
pathogenesi
ba
earli
stage
diseas
humoralrel
gene
ie
immunoglobulin
transient
suppress
howev
b
lymphocyt
seem
play
role
antigen
present
cell
effector
cell
activ
also
shown
figur
evid
role
b
lymphocyt
propos
studi
deplet
bcell
experiment
ba
associ
impair
effector
tcell
activ
protect
biliari
injuri
furthermor
humor
ductspecif
autoimmun
demonstr
experiment
ba
role
b
lymphocyt
remain
unclear
human
ba
humanbas
studi
regard
humor
activ
ba
includ
descript
immunoglobulin
igm
igg
deposit
biliari
epithelium
basement
membran
detect
autoantibodi
lu
et
al
detect
autoantibodi
rrv
induc
mous
model
ba
serum
sampl
patient
indic
role
humor
autoimmun
diseas
pathogenesi
crossreact
antienolas
antibodi
rrv
protein
indic
molecular
mimicri
might
activ
humor
autoimmun
ba
patient
howev
investig
need
provid
insight
implic
humor
immun
ba
subset
helper
cell
known
regulatori
cell
treg
express
forkhead
box
pivot
role
immunoregul
induct
peripher
toler
neonat
treg
prevent
activ
autoreact
cell
inhibit
action
sever
immunocompet
cell
b
cell
macrophag
dendrit
cell
natur
killer
cell
neonat
mice
treg
popul
spleen
day
life
correspond
suscept
time
window
rrv
model
moreov
adopt
transfer
treg
pup
rrv
infect
prevent
obstruct
extrahepat
bile
duct
infant
ba
gene
express
regulatori
cytokin
transform
growth
factor
transcript
factor
upregul
liver
deficit
number
circul
treg
peripher
blood
regulatori
function
seem
impair
even
though
exact
underli
mechan
treg
malfunct
immun
dysregul
fulli
understood
epigenet
chang
might
play
major
role
instanc
hypomethyl
promot
associ
improp
function
treg
hypermethyl
dna
lymphocyt
elicit
promot
exacerb
inflammatori
respons
obstruct
regardless
restor
bile
flow
immunemedi
biliari
damag
persist
initi
milieu
shift
toward
simultan
emerg
subset
figur
one
hand
apoptot
necrot
cell
releas
endogen
molecul
known
damageassoci
molecular
pattern
damp
recogniz
prrsa
excess
damag
danger
signal
one
damp
interleukin
releas
cholangiocyt
hepatocyt
accumul
extracellular
matrix
ecm
promot
inflamm
fibrosi
high
level
detect
serum
tissu
biopsi
patient
experiment
ba
context
liver
believ
engag
liverresid
innat
helper
cell
express
receptor
produc
profibrot
cytokin
among
upregul
express
matrix
metalloproteinas
activ
hsc
via
promot
fibrosi
mechan
stimul
collagen
synthesi
myofibroblast
activ
hsc
portal
fibroblast
simultan
shown
drive
duct
prolifer
intraand
extrahepat
duct
axi
depict
figur
hand
damag
cholangiocyt
shown
produc
requir
commit
need
mainten
phenotyp
repres
cytokin
panel
induc
product
sever
proinflammatori
cytokin
chemokin
lage
et
al
identifi
cell
main
sourc
obstruct
biliari
tree
experiment
ba
studi
model
biliari
injuri
perpetu
propos
stimul
cholangiocyt
produc
cc
motif
chemokin
ligand
recruit
inflammatori
macrophag
express
target
epithelium
shown
figur
model
deplet
cell
blockag
prevent
bile
duct
pauciti
number
cell
correl
concentr
gamma
glutamyl
transpeptidas
ggt
biochem
marker
bile
duct
injuri
ba
patient
presenc
biliari
tree
peripher
blood
confirm
well
marker
liver
tissu
frontier
immunolog
wwwfrontiersinorg
retino
acidrel
orphan
receptor
ror
serum
addit
high
ratio
treg
character
peripher
blood
trend
also
observ
chronic
liver
diseas
primari
biliari
cirrhosi
addit
damag
proapoptot
well
inflammatori
cell
especi
kupffer
cell
macrophag
express
produc
hedgehog
hh
ligand
patholog
condit
cholangiocyt
stimul
hh
ligand
autocrin
paracrin
manner
produc
wide
assort
cytokinesinclud
chemokin
attract
differ
popul
inflammatori
cell
includ
neutrophil
monocyt
lymphocyt
inflammatori
cell
stimul
hh
ligand
sustain
inflamm
activ
hsc
continu
prolifer
respons
stimulu
abnorm
overactiv
hedgehog
pathway
observ
context
chronic
inflammationrel
fibrosi
human
cholangiopathi
biliari
atresia
characterist
hh
ligand
ba
osteopontin
opn
correl
sever
diseas
like
cell
macrophag
adopt
differ
polar
state
depend
surround
tissu
microenviron
character
function
program
import
sinc
seem
vast
implic
outcom
sever
chronic
autoinflammatori
degen
diseas
convent
divid
classic
activ
proinflammatori
altern
activ
restor
macrophag
polar
macrophag
driven
activ
tlr
signal
lp
challeng
stimul
regulatori
cytokin
prime
polar
sever
report
point
mani
context
dichotomi
may
suffici
describ
relev
macrophag
popul
heterogen
complex
activ
stimuli
surround
tissu
microenviron
howev
context
fibrosi
two
distinct
macrophag
popul
describ
role
modul
bodi
respons
chronic
injuri
profibroinflammatori
resolut
macrophag
often
associ
featur
respect
polar
abil
influenc
tissu
microenviron
net
cellular
respons
outcom
diseas
instanc
proinflammatori
macrophag
display
high
level
inflammatori
marker
lymphocyt
antigen
complex
locu
c
character
high
product
chemokin
attract
inflammatori
cell
site
injuri
proinflammatori
cytokin
perpetu
hepat
damag
activ
hsc
ecmproduc
myofibroblast
contrari
restor
macrophag
display
low
level
seem
respons
induc
hsc
apoptosi
trail
digest
excess
ecm
promot
clearanc
profibrot
stimuli
therebi
facilit
tissu
regener
tissueresid
monocytederiv
macrophag
acquir
function
program
howev
latter
predomin
popul
tissu
injuri
highlight
relev
infiltr
inflammatori
cell
cours
diseas
profibroinflammatori
macrophag
exhibit
wide
assort
mechan
allow
activ
perpetu
inflamm
fibrosi
independ
circuit
one
way
modul
surround
cellular
respons
influenc
tissu
microenviron
import
compon
microenviron
level
oxid
stress
intim
link
advanc
glycat
endproduct
age
receptor
age
rage
pathway
age
refer
heterogen
group
toxic
byproduct
result
irrevers
nonenzymat
reaction
sugar
protein
consequ
elev
intracellular
oxid
speci
normal
physiolog
condit
age
produc
small
amount
releas
extracellular
space
clear
special
phagocyt
cell
princip
macrophag
scaveng
receptor
figur
howev
chronic
injuri
continu
oxid
stress
product
age
higher
clearanc
lead
accumul
extracellular
space
affect
surround
cell
interact
age
orand
rage
ligand
protein
receptor
trigger
signal
transduct
cascad
differ
pathway
result
numer
cellular
respons
inflamm
fibrosi
apoptosi
depict
figur
murin
model
rrv
abil
infect
macrophag
result
activ
activ
proinflammatori
macrophag
one
main
sourc
age
damag
cholangiocyt
hepatocyt
also
shown
produc
sever
rage
ligand
respons
injuri
patient
ba
serum
level
solubl
rage
correl
sever
diseas
recent
network
analysi
studi
involv
three
main
human
cholangiopathi
includ
ba
identifi
common
connectom
agerag
pathway
occupi
central
node
remark
observ
induct
oxid
speci
product
agerag
ligand
rrvinfect
cholangiocyt
unpublish
work
suggest
involv
oxid
stress
circuit
onset
diseas
routin
treatment
ba
patient
hpe
ursodeoxychol
acid
antibiot
fatsolubl
vitamin
formul
substanti
improv
outcom
diseas
doubleblind
placebocontrol
studi
start
trial
corticosteroid
administr
within
day
hpe
chang
outcom
ba
cohort
increas
risk
seriou
advers
effect
compar
placebo
control
although
corticosteroid
ba
infant
younger
week
age
appear
improv
biliari
drainag
pend
data
nativ
liver
surviv
suggest
possibl
corticosteroid
use
subset
infant
futur
agent
current
test
cholestat
fibrot
liver
diseas
adult
also
investig
ba
farnesoid
x
receptor
fxr
agonist
obetichol
acid
modifi
bile
acid
norursodeoxychol
acid
also
current
use
primari
biliari
cholang
pbc
primari
scleros
cholang
psc
patient
agent
apic
sodiumdepend
bile
acid
transport
asbt
inhibitor
may
reduc
bile
acid
burden
liver
two
agent
current
use
clinic
pediatr
liver
diseasesbil
acid
sequestr
cholestyramin
colesevelam
ursodeoxychol
acidar
yet
thoroughli
test
clinic
trial
ba
due
establish
experiment
model
ba
especi
rrv
murin
model
drive
mechan
epitheli
injuri
duct
obstruct
elucid
correspond
key
cellular
molecular
target
identifi
howev
real
applic
target
therapi
hinder
due
lack
earli
diagnosi
screen
tool
mani
question
regard
etiolog
diseas
remain
unansw
molecular
cellular
mechan
diseas
progress
still
investig
increas
evid
suggest
deeper
implic
intric
mechan
innat
immun
onset
diseas
name
oxid
stress
alter
metabol
induct
longtermabnorm
epigenet
chang
among
agerag
pathway
attract
attent
sinc
encompass
key
circuit
involv
pathogenesi
sever
chronic
inflammatori
degen
diseas
includ
biliari
atresia
investig
need
determin
extent
implic
agerag
pathway
crosstalk
fibroinflammatori
circuit
macrophag
one
main
driver
agerag
function
polar
seem
occupi
central
role
modul
tissu
respons
outcom
chronic
condit
futur
research
interrog
cell
popul
context
biliari
atresia
imper
need
develop
new
improv
exist
experiment
platform
perform
mechanist
studi
later
event
diseas
facilit
identif
implic
cell
popul
pathway
addit
deeper
understand
model
induct
virus
andor
toxin
could
shed
light
etiolog
diseas
aid
develop
new
therapi
manag
ba
patient
without
need
surgeri
aop
draft
manuscript
bd
ht
rb
gt
sm
support
write
manuscript
implement
ensur
scientif
qualiti
aop
rb
sm
design
figur
aop
rb
gt
sm
made
final
correct
author
correct
approv
manuscript
work
support
part
nation
institut
health
grant
gt
sm
